Clinical presentation and protocol for management of hepatic sarcoidosis

References

• Methodology manual for ACC/AHA Guideline Writing Committees. Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines April 2006. 2006
   Google Scholar
• Vardhanabhuti V, Venkatanarasimha N, Bhatnagar G, et al. Extra-pulmonary manifestations of sarcoidosis. Clin Radiol 2012;67:263-76
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). 2001;164(11):2085-91
   Google Scholar
• Sverrild A, Backer V, Kyvik KO, et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 2008;63(10):894-6
   PubMed Web of Science ®Google Scholar
• Hercules HD, Bethlem NM. Value of liver biopsy in sarcoidosis. 1984;108(10):831-4
   Google Scholar
• Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? Yale J Biol Med 2012;85(1):133-41
   PubMedGoogle Scholar
• Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet 2008;73(5):401-12
   PubMed Web of Science ®Google Scholar
• Brownell I, Ramírez-Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011;45(5):899-905
   PubMed Web of Science ®Google Scholar
• Cozier YC, Berman JS, Palmer JR, et al. Sarcoidosis in black women in the United States: data from the Black Women’s Health Study. Chest 2011;139(1):144-50
   PubMed Web of Science ®Google Scholar
• Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006;5(4):251-6
   PubMedGoogle Scholar
• Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon 2009;55(11):675-92
   PubMedGoogle Scholar
• Kahi CJ, Saxena R, Temkit M. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23(2):117-23
   PubMed Web of Science ®Google Scholar
• Coash M, Forouhar F, Wu CH, Wu GY. Granulomatous liver diseases: a review. J Formos Med Assoc 2012;111(1):3-13
   PubMed Web of Science ®Google Scholar
• Gaya DR, Thorburn D, Oien KA, et al. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol 2003;56(11):850-3
   PubMed Web of Science ®Google Scholar
• Bilir M, Mert A, Ozaras R. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000;31(4):337-8
   PubMed Web of Science ®Google Scholar
• Maddrey WC, Johns CJ, Boitnott JK, Iber FL. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) 1970;49(5):375-95
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Major M, Popovich JJr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145(3):234-41
   PubMed Web of Science ®Google Scholar
• Martin-Blondel G, Camara B, Selves J. Etiology and outcome of liver granulomatosis: a retrospective study of 21 cases. Rev Med Interne 2010;31(2):97-106
   PubMed Web of Science ®Google Scholar
• Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 1998;73(5):467-72
   PubMed Web of Science ®Google Scholar
• Judson MA. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 2002;23(6):529-41
   PubMed Web of Science ®Google Scholar
• Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006;5(4):251-6
   PubMedGoogle Scholar
• Israel HL, Kataria YP, Liberman J. Clinical aspects of sarcoidosis. Sarcoidosis 1985;7-23
   Google Scholar
• Bilir M, Mert A, Ozaras R. Hepatic Sarcoidosis: clinciopathological features in thirty-seven patients. J Clin Gastroentol 2000;31(4):337-8
   PubMed Web of Science ®Google Scholar
• Samman Y, Ibrahim M, Wali S. Sarcoidosis in the western region of Saudi Arabia. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(2):215-18
   PubMed Web of Science ®Google Scholar
• Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997;26(3):554-60
   PubMed Web of Science ®Google Scholar
• Murphy JR, Sjogren MH, Kikendall JW, et al. Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol 1990;12(5):555-61
   PubMed Web of Science ®Google Scholar
• Russi EW, Bansky G, Pfaltz M, et al. Budd-Chiari syndrome in sarcoidosis. Am J Gastroenterol 1986;81(1):71-5
   PubMed Web of Science ®Google Scholar
• Nataline MR, Goyette RE, Owensby LC, Rubin RN. The Budd-Chiari syndrome in sarcoidosis. JAMA 1978;239(25):2657
   PubMed Web of Science ®Google Scholar
• Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand 1977;202(4):289-93
   PubMedGoogle Scholar
• Valla D, Pessegueiro-Miranda H, Degott C, et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature.Q J Med 1987;63(242):531-44
   Google Scholar
• Tekeste H, Latour F, Levitt RE. Portal hypertension complicating sarcoid liver disease: case report and review of the literature. Am J Gastroenterol 1984;79(5):389-96
   PubMed Web of Science ®Google Scholar
• Cremers J, Drent M, Driessen A. Liver-test abnormalities in sarcoidosis. Nieman F. Eur J Gastroenterol Hepatol 2012;24(1):17-24
   PubMed Web of Science ®Google Scholar
• Kessler A, Mitchell DG, Israel HL, Goldberg BB. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging 1993;18(2):159-63
   PubMedGoogle Scholar
• Britt AR, Francis IR, Glazer GM, Ellis JH. Sarcoidosis: abdominal manifestations at CT. Radiology 1991;178(1):91-4
   PubMed Web of Science ®Google Scholar
• Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004;24(1):87-104
   PubMed Web of Science ®Google Scholar
• Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008;103(12):3184-92
   PubMed Web of Science ®Google Scholar
• Flickinger FW, Pfeifer EA. Hepatic sarcoidosis: MR findings. AJR Am J Roentgenol 1991;156(6):1324-5
   PubMed Web of Science ®Google Scholar
• Kitamura M, Ishizaki T. Sarcoidosis of the liver and spleen in Japan. Nihon Rinsho 1994;52(6):1595-8
   PubMedGoogle Scholar
• Hoeffel C, Bokemeyer C, Hoeffel JC, et al. CT hepatic and splenic appearances with sarcoidosis. Eur J Radiol 1996;23(2):94-6
   PubMed Web of Science ®Google Scholar
• Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995;195(3):757-62
   PubMed Web of Science ®Google Scholar
• Farman J, Ramirez G, Brunetti J, et al. Abdominal manifestations of sarcoidosis. CT appearances. Clin Imaging 1995;19(1):30-3
   PubMed Web of Science ®Google Scholar
• Nakata K, Iwata K, Kojima K, Kanai K. Computed tomography of liver sarcoidosis. J Comput Assist Tomogr 1989;13(4):707-8
   PubMed Web of Science ®Google Scholar
• Warshauer DM, Semelka RC, Ascher SM. Nodular sarcoidosis of the liver and spleen: appearance on MR images. J Magn Reson Imaging 1994;4(4):553-7
   PubMed Web of Science ®Google Scholar
• Cremers JP, Van Kroonenburgh MJ, Mostard RL, et al. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 2014;31(1):37-45
   PubMed Web of Science ®Google Scholar
• Treglia G, Annunziata S, Sobic-Saranovic D, et al. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol 2014;21:675-84
   PubMed Web of Science ®Google Scholar
• Coash M, Forouhar F, Wu CH, Wu GY. Granulomatous liver diseases: a review. J Formos Med Assoc 2012;111(1):3-13
   PubMed Web of Science ®Google Scholar
• Flamm SL. Granulomatous liver disease. Clin Liver Dis 2012;16(2):387-96
   PubMed Web of Science ®Google Scholar
• McCluggage WG, Sloan JM. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology 1994;25(3):219-28
   PubMed Web of Science ®Google Scholar
• Drebber U, Kasper HU, Ratering J, et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis–a study of 442 cases. Liver Int 2008;28(6):828-34
   PubMed Web of Science ®Google Scholar
• Gaya DR, Thorburn D, Oien KA, et al. Hepatic granulomas: a 10 year single center experience. J Clin Pathol 2003;56:850-3
   PubMed Web of Science ®Google Scholar
• Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007;28(1):36-52
   PubMed Web of Science ®Google Scholar
• Dourakis SP, Saramadou R, Alexopoulou A. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 2007;19(2):101-4
   PubMed Web of Science ®Google Scholar
• Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993;17(12):1272-80
   PubMed Web of Science ®Google Scholar
• Mueller S, Boehme MW, Hofmann WJ, Stremmel W. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol 2000;35(9):1003-8
   PubMed Web of Science ®Google Scholar
• Bécheur H, Dall’osto H, Chatellier G. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci 1997;42(4):789-91
   PubMed Web of Science ®Google Scholar
• Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci 2005;50(1):196-200
   PubMed Web of Science ®Google Scholar
• Baratta L, Cascino A, Delfino M. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci 2000;45(8):1559-62
   PubMed Web of Science ®Google Scholar
• Malhotra A, Naniwadekar A, Sood G, et al. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 2008;23(12):1942
   PubMed Web of Science ®Google Scholar
• Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr 2011;30(4):506-12
   PubMed Web of Science ®Google Scholar
• Hughes GSJr, Kataria YP, O’Brien TFJr. Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J 1983;76(11):1440-2
   PubMed Web of Science ®Google Scholar
• Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299(3):153-7
   PubMed Web of Science ®Google Scholar
• Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Papadopoulou AM, Eur J Gastroenterol Hepatol 2006;18(7):721-6
   PubMed Web of Science ®Google Scholar
• Casavilla FA, Gordon R, Wright HI, et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993;118(11):865-6
   PubMed Web of Science ®Google Scholar
• Das D, Smith A, Warnes TW. Hepatic sarcoidosis and renal carcinoma. J Clin Gastroenterol 1999;28(1):61-3
   PubMed Web of Science ®Google Scholar
• Nguyen YT, Dupuy A, Cordoliani F, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004;50(2):235-41
   PubMed Web of Science ®Google Scholar
• Lazar CA, Culver DA. Treatment of sarcoidosis. Semin Respir Crit Care Med 2010;31(4):501-18
   PubMed Web of Science ®Google Scholar
• Park MK, FontanaJr, Babaali H. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009;26(2):121-31
   PubMed Web of Science ®Google Scholar
• Ulbricht KU, Stoll M, Bierwirth J, et al. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003;48(12):3542-3
   PubMed Web of Science ®Google Scholar
• Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005;127(3):1064-71
   PubMed Web of Science ®Google Scholar
• Saleh S, Ghodsian S, Yakimova V, et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006;100(11):2053-9
   PubMed Web of Science ®Google Scholar
• Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extra pulmonary sarcoidosis: results from a randomized trial. Eur Respir J 2008;31(6):1189-96
   PubMed Web of Science ®Google Scholar
• Sahoo DH, Bandyopadhyay D, Xu M, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011;38(5):1145-50
   PubMed Web of Science ®Google Scholar
• Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl 2011;17(9):1027-34
   PubMed Web of Science ®Google Scholar
• Moller DR. Treatment of sarcoidosis – from a basic science point of view. J Intern Med 2003;253(1):31-40
   PubMed Web of Science ®Google Scholar
• Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond) 2007;112(5):281-9
   PubMed Web of Science ®Google Scholar
• Ayyala US, Padilla ML. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 2006;9(6):475-83
   PubMedGoogle Scholar
• Wu JJ, Schiff KR. SarcoidosisAm Fam Physician. 2004;70(2):312-22
   Google Scholar
• Cremers JP, Drent M, Baughman RP, et al. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med 2012;18(5):472-82
   PubMed Web of Science ®Google Scholar
• Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001(Suppl 32):56s-68s
   Google Scholar
• Kahi CJ, Saxena R, Temkit M, et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23(2):117-23
   PubMed Web of Science ®Google Scholar
• Ratziu V, de Ledinghen V, Oberti F, et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2011;54(5):1011-19
   PubMed Web of Science ®Google Scholar
• Kuiper EM, Hansen BE, Adang RP, et al. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. Eur J Gastroenterol Hepatol 2010;22(12):1495-502
   PubMed Web of Science ®Google Scholar
• Wan Y. TMPT testing before azathioprine therapy? Drug Ther Bull 2009;47:9-12
   PubMedGoogle Scholar
• Visentin M, Zhao R, Goldman ID. The antifolates. Hematol Oncol Clin North Am 2012;26(3):629-48
   PubMed Web of Science ®Google Scholar
• Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;157(16):1864-8
   PubMedGoogle Scholar
• Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003;124(5):2023-6
   PubMed Web of Science ®Google Scholar
• Lipson EJ, Fiel MI, Florman SS, Korenblat KM. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005;19(4):487-91
   PubMed Web of Science ®Google Scholar
• Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al. Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl 2005;11(12):1611-14
   PubMed Web of Science ®Google Scholar
• Hunt J, Gordon FD, Jenkins RL, et al. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999;12(3):325-8
   PubMed Web of Science ®Google Scholar